CMed Clinical Services Published on 31/01/11 at 11:36am The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to government figures. Over 84% of girls now aged 13-14 have received all three doses of GlaxoSmithKline’s Cervarix, which blocks the human papillomavirus (HPV). Since HPV is the […]
Search Results for: gardasil
Estrogen is to Cancer what Fertilizer is to Wheat
Estrogen & HPV Stimulation – Did Merck Conduct the Studies for Gardasil? FOR IMMEDIATE RELEASE PRLog (Press Release) – Jan 31, 2011 – It appears history has repeated itself many times since January 1970, when a Senate testimony hearing on the safety and efficacy of the first birth control pill was conducted after pressure from […]
The Fight Back – Reporting from the streets of the District of Columbia
Is D.C.’s HPV Vaccine Mandate a Mistake? Last April, as Emily Tarsell began her trek back to Northern Maryland following her testimony before the D.C. Council, she said, “I came down to try to support the families in Washington to be more aware of the [possible] adverse side effects of [the Human Papillomavirus vacine] Gardasil […]
Girls opting out of HPV shots
Girls opting out of HPV shots
Less than half of Grade 8 females got the three-dose vaccination against HPV
By Kelly Pedro The London Free Press
Last Updated: January 28, 2011 12:17pm
More than half of Grade 8 girls in London-Middlesex still aren’t getting vaccinated against a virus linked to cervical cancer, disappointing health officials.
Last year, about 45% of local girls received the three doses paid for by the federal government.
“We’d like to be higher, obviously. We’d like to be at 100, but we’d like to be more toward 70%,” said Dr. Bryna Warshawsky, associate medical officer of health at the Middlesex-London Health Unit. The health unit started administering the Gardasil vaccine through a school-based program in 2007.
At the time, 39% of Grade 8 girls got the three-dose shots, each costing $150. Gardasil is designed to protect against four types of the sexually-transmitted human papilloma virus, two of which are blamed for 70% of cervical cancer cases.
SaneVax Introduces One More Cervarix Girl: Lara from Wales
By Norma Erickson, President of SaneVax Inc. Lara’s story is but another in the line of tragedies following GlaxoSmithKline’s “Armed for Life” marketing campaign for Cervarix. Prior to Cervarix, Lara was every mother’s dream child. She didn’t cry, finished her bottles in the blink of an eye and was always smiling. As she grew, […]
- « Previous Page
- 1
- …
- 211
- 212
- 213
- 214
- 215
- …
- 246
- Next Page »
